Topics
Glioblastoma | Treatment | Immunotherapy | Viruses
Home > Publications > Topics > Glioblastoma > Treatment > Immunotherapy > Viruses
*Rossmeisl JH, King JN, Robertson JL, Weger-Lucarelli J,
Elankumaran S.
Phase I/II Trial of
Urokinase Plasminogen Activator-Targeted Oncolytic Newcastle
Disease Virus for Canine Intracranial Tumors.
Cancers
(Basel). 2024 Jan 29;16(3):564. doi:
10.3390/cancers16030564. PMID:
38339315. Interventional animal study. ˍ
Calderón-Peláez MA, Maradei Anaya SJ,
Bedoya-Rodríguez IJ, González-Ipuz KG, Vera-Palacios
D, Buitrago IV, Castellanos JE, Velandia-Romero ML.
Zika
Virus: A Neurotropic Warrior against High-Grade Gliomas-Unveiling
Its Potential for Oncolytic Virotherapy.
Viruses.
2024 Apr 3;16(4):561. doi:
10.3390/v16040561. PMID:
38675903;. Review. ˍ